Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1586
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRegNo:BN0120005-
dc.date.accessioned2023-12-11T10:45:26Z-
dc.date.available2023-12-11T10:45:26Z-
dc.date.issued2023-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1586-
dc.description.abstractBACKGROUND - The coronavirus disease, also known as COVID-19, was first reported in Wuhan, Hubei, China in December 2019 and has rapidly evolved from an epidemic outbreak into a global pandemic infecting over thirteen million people worldwide. The SARS-COV2 virus has been identified as the causative agent. The first covid-19 case in India was reported on January 30, 2020, from Kerala, with a positive travel history to Wuhan. Covid-19 is a systemic viral infection that affects the hematopoietic system, haemostasis, and immune system. There is correlation between complete blood count (CBC) parameters, coagulation profile like D-dimer, biochemical markers (ferritin, CRP) and disease progression. OBJECTIVES - To correlate blood parameter and inflammatory markers like D dimer, Ferritin, C-Reactive Protein, Neutrophil Lymphocyte Ratio and lymphocyte count in survivors and non survivors of COVID-19 positive patients.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectKEY WORDS - COVID-19, SARS-COV2, D-dimer, Ferritin, C-Reactive Protein, Neutrophil Lymphocyte Ratio and lymphocyte counten_US
dc.titleCORRELATION OF BLOOD PARAMETERS WITH OUTCOME IN COVID -19 POSITIVE PATIENTSen_US
dc.typeDissertationsen_US
Appears in Collections:Pathology

Files in This Item:
File Description SizeFormat 
BN0120005.pdf3.47 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.